Search IPOs
IGCL · NSE,BSE · Pesticides & Agrochemicals
Indogulf Cropsciences IPO listed on 03 Jul 2025 on NSE,BSE at ₹111.00, a gain of 0.00% over the issue price of ₹111.00. The IPO was subscribed 25.98x overall.
Indogulf Cropsciences IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 26 Jun 2025 |
| IPO Close Date | 30 Jun 2025 |
| Basis of Allotment | 01 Jul 2025 |
| Initiation of Refunds | 02 Jul 2025 |
| Credit of Shares to Demat | 02 Jul 2025 |
| Listing Date | 03 Jul 2025 |
Listing day gain
+0%
Listed at ₹111 (issue ₹111)
Issue
₹111
Listing
₹111
Current
₹110.35
-0.59% vs issue
Day range
₹106 – ₹113
Issue Size
18,040,144 shares
(aggregating up to ₹200.00 Cr)
Issue Price
₹105 – ₹111
Face Value
₹10/share
Market Lot
135 shares
Retail Min Investment
₹14,985
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
14,436,541 shares
(aggregating up to ₹160.05 Cr)
Offer for Sale
3,603,603 shares
(aggregating up to ₹39.95 Cr)
Issue Type
book building
Open Date
26 Jun
Close Date
30 Jun
Allotment
01 Jul
Listing
03 Jul
Last updated: 1 year ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 03 Jul 2025 Latest | ₹111 | ₹18 | ₹129 | ₹18 |
16.22%
|
12:00 AM |
| 02 Jul 2025 | ₹111 | ₹18 | ₹129 | ₹18 |
16.22%
|
12:00 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 30 Jun 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 33.26x |
| NII | 48.39x |
| bNII (bids above ₹10L) | 51.41x |
| sNII (bids below ₹10L) | 42.34x |
| Retail Investors | 14.78x |
| Employees | 1.09x |
| Total | 25.98x |
Showing the latest subscription snapshot.
View full subscription historyOm Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal and Arnav Aggarwal are the promoters of the company.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 135 | ₹14,985 |
| Retail (Max) | 13 | 1,755 | ₹194,805 |
| S-HNI (Min) | 14 | 1,890 | ₹209,790 |
| S-HNI (Max) | 66 | 8,910 | ₹989,010 |
| B-HNI (Min) | 67 | 9,045 | ₹1,003,995 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 8,738,737 (48.34%) |
|
•
Anchor Investor Shares Offered
|
5,243,242 (29.00%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
3,495,495 (19.34%) |
| NII (HNI) Shares Offered | 2,621,622 (14.50%) |
|
•
bNII > ₹10L
|
1,747,748 (9.67%) |
|
•
sNII < ₹10L
|
873,874 (4.83%) |
| Retail Shares Offered | 6,117,117 (33.84%) |
| Employee | 600,000 (3.32%) |
| Total Shares Offered | 18,077,476 (100.00%) |
Indogulf Cropsciences Limited was incorporated in 1993 and is headquartered in Delhi. It works in the agrochemicals manufacturing sector.
The company manufactures and markets crop protection products, plant nutrients, and biologicals, with crop protection products accounting for around 95% of FY24 revenue. Its products are sold domestically and exported to 34 countries, and the company holds "Two Star" export house recognition. As of August 31, 2024, its distribution network comprised 169 institutional business partners, 5,772 domestic distributors, 17 stock depots, six sales and branch offices, and 129 overseas business partners.
On a restated basis, revenue from operations rose from Rs 487.21 crore in FY22 to Rs 549.66 crore in FY23 to Rs 552.23 crore in FY24, while profit after tax moved from Rs 26.36 crore to Rs 22.42 crore to Rs 28.23 crore over the same period. The IPO was a mainboard, book-built issue of Rs 200 crore, comprising a fresh issue aggregating up to Rs 160 crore and an offer for sale of up to 36,03,603 equity shares aggregating up to Rs 40 crore, at a price band of Rs 105 to Rs 111 per share, listed on the BSE and NSE. As per the RHP, net proceeds from the fresh issue were proposed to be used for repayment or prepayment of certain borrowings (about Rs 34.1 crore), funding working capital requirements (about Rs 65 crore), and setting up a dry flowable plant in Barwasni, Haryana (about Rs 14 crore), with the balance for general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2023 | FY Mar 2024 | FY Dec 2024 |
|---|---|---|---|
| Total Revenue | 552.19 | 555.79 | 466.31 |
| Profit After Tax (PAT) | 22.42 | 28.23 | 21.68 |
| EBITDA | 49.04 | 55.74 | 44.78 |
| Total Assets | 517.51 | 542.25 | 597.81 |
| Net Worth | 203.25 | 231.65 | 265.43 |
| Reserves & Surplus | 179.6 | 208.01 | 216.64 |
| Total Borrowing | 189.22 | 154.56 | 206.3 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | FY 2024 | Mar 2024 |
|---|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 12.2% | 12.2% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 11.93% | 11.93% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 12.19% | 12.19% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 5.11% | 5.11% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 10.09% | 10.09% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 0.67x | 0.67x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 1.13x | 1.13x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹5.79 | ₹4.57 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 19.18x | 24.27x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹542 Cr | ₹698 Cr |
The basis of allotment for Indogulf Cropsciences IPO was finalised on 01 Jul 2025. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The Indogulf Cropsciences IPO is expected to open in Jun 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Indogulf Cropsciences IPO is ₹105.00 - ₹111.00 per share.
As per market sources, Indogulf Cropsciences IPO GMP is currently ₹18.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Indogulf Cropsciences IPO stands at 25.98x overall.
The listing date for Indogulf Cropsciences IPO is 03 Jul 2025.
No comments yet. Be the first to comment!
